DBV Technologies Reports Q1 2021 Financial Results
May 03, 2021 01:30 ET | Source: DBV Technologies S.A. DBV Technologies S.A.
DBV Technologies Financial Results
DBV Technologies S.A. (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported financial results for the first quarter of 2021. The quarterly financial statements were approved by the Board of Directors on April 30, 2021.
“
through the first quarter of 2021,” said Daniel Tasse, Chief Executive Officer, DBV Technologies. “
We remain diligent about our spend and confident that
our cash on hand as of March 31, 2021 will support our operations
until the second half of 2022. We continue to focus our attention on advancing
DBV Technologies S.A.: DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments
DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments
DBV Technologies S.A. (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported financial results for the year ended December 31, 2020. The financials have been audited by the Company s statutory auditors and were approved by the Board of Directors on March 11, 2021. The audit report will be issued by the Company s auditors in March 2021.
DBV ended 2020 well positioned to advance Viaskin Peanut towards potential approval in both the United States and European Union, said Daniel Tasse, Chief Executive Officer of DBV Technologies.
Trending Penny Stocks To Watch For The End Of The Week
As we inch further into 2021, investors continue to focus on penny stocks. But, if this year has shown us anything, itâs that volatility and speculation are both very high. During this week, several factors have been impacting the trajectory of the stock market.
In the U.S., the implications of a Biden presidency and the current political turmoil, are big factors to consider. Interestingly enough, this week has been relatively calm for many blue-chip stocks. But, as always, the action amongst cheaper stocks is much higher. As we turn the corner in January, investors seem to be focused on a few industries in particular.Â
UK EXECUTIVE CHANGE SUMMARY: M&G Chair Evans Takes Temporary Break
Mon, 11th Jan 2021 14:58
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:
M&G PLC - London-based asset manager - Chair Mike Evans takes temporary leave of absence due to stress-related illness. No other details are provided. Senior Independent Director Fiona Clutterbuck to be interim chair, while Clare Thompson will be interim senior independent director. Clutterbuck also is chair of Paragon Banking Group PLC and of Nordic financial services group Sampo.
Bowleven PLC - Africa-focused oil and gas exploration - Promotes Non-Executive Director Jack Arnoff to chair, effective immediately. Arnoff joined the Bowleven board back in November. Company said Arnoff takes over as it targets a final investment decision at its Etinde project in Cameroon during 2021.